SCYRX
scyrx.com
Email me when this record changes
Following this record emails you when it gains a dated entry or its published claims are re-read, and nothing about any other supplier. No topic below is ticked: tick one only if you also want it in the same email.
Compiled automatically from the dated observations in this vendor's record. How we evaluate.
Never merged into one number. Some supplier links here are referral links, marked where they appear, which pay Terminus Research when a reader buys. The same terms are open to every supplier in the ledger, apart from the one exception the referral policy page names, participation changes no score, rank, caution, or coverage decision, and a link is not an endorsement.
SCYRX publishes no certificate of analysis anywhere on the site, for retatrutide or any of its 25 other catalog items; the only route to one is a "Request COA" lead-capture button promising an emailed document within a business day, and the standard commerce pages a buyer would expect, /contact, /shipping, /terms, and /privacy, all return 404 despite footer links labeled for each of them. The homepage's five named testimonials citing specific batch-purity readings are printed twice on the same page as a duplicated block, with no institution or contactable source behind any of them, and the site carries a live "Edit with Lovable" developer badge marking it as built on a no-code platform. Has anyone who submitted the COA request actually received a certificate back, and if so, does it name a testing laboratory at all?
What the record holds
NO FIRM COMMITMENT
“a 2-day shipping guarantee backed by a stated $15 credit if a shipment runs late”
No shipping policy page exists on the site (/shipping returns 404); the guarantee's own conditions, such as which orders qualify or what counts as late, are not published anywhere. No carrier or rate stated either.
Read from this supplier's own pages on 2026-08-26. This publication has never placed an order with any supplier. This row records what is written and measures nothing about what actually happens after an order.
$32.00
Compound retatrutide 10mg
Listed as Retatrutide 10mg, product page titled "Retatrutide - Triple GLP-1/GIP/Glucagon Receptor Agonist"
Price as recorded $32.00 USD for the 10mg vial, in stock. Other sizes on the same page: 5mg $22.00 (sold out), 20mg $50.00, 30mg $65.00 (sold out), 40mg $78.00, 60mg $95.00, plus an automatic 5 percent discount on orders of three or more items
Read on 2026-08-26. One reading on one day, and prices are not tracked over time here.
This supplier was not part of the Trustpilot reading of 2026-08-25, which covered 59 of the 126 suppliers on file. That is a fact about this publication's coverage, stated rather than left to be read either way.
4 claims from this publication's own dossier on this supplier were read again against the live site on 2026-08-26: 1 held, 3 corrected before publication.
A corrected claim is an error of ours that the re-read caught before it reached a page. This line tracks this publication's own accuracy. It says nothing about the supplier.
Dated entries
4 observations on file, recorded 2026-08-26. Newest first, appended and never rewritten.
No certificate of analysis is published anywhere on the site I could find. The product page for Retatrutide 10mg shows a purity claim reading at least 99 percent by HPLC beside the price, and a specifications table further down repeats a purity figure of 99 percent or greater by HPLC, with a footnote that formulation ratios and purity metrics may vary by batch and that buyers should refer to the batch-specific Certificate of Analysis included with an order. The only way to obtain that document is a "Request COA" button beside the Add to Cart control; the copy under it states the certificate is issued by email to verify authenticity, with a reply promised within one business day. I did not submit that request, since it is a lead-capture form rather than a document link, so no certificate for Retatrutide, or for any other compound on the site, was available to open. I checked for a public library under every path pattern the other two vendors in this wave use: /coa, /coas, /lab-results/, /certificates, /certificate-of-analysis, /testing, plus /about and /faq. All eight returned 404 on scyrx.com today. The site's own sitemap.xml lists 41 URLs total and none of them is a documentation or certificate page. No named testing laboratory appears anywhere across the home page, the Retatrutide product page, the Wholesale Access page or the Research Blog; every reference to testing says only "third-party," "independent," or "our lab documentation" without naming an entity, an address, or an accreditation. The homepage's "Purity Promise" section ties its refund to a purity reading below 99 percent returned by "your lab or any accredited facility," which places the verification burden on the buyer's own outside testing rather than on a document the vendor supplies before purchase. The one identity-adjacent data on the specifications table that is not marketing copy: a molecular weight of approximately 4,791.38 g/mol for the acetate-salt form SCYRX sells (the page separately tabulates a free-base reference weight of 4,731.33 g/mol for comparison), a CAS number of 2381089-83-2, and a PubChem CID of 171390338, all of which match the published identity for retatrutide in general chemical references. Matching the compound's identity in a reference database is not the same as verifying this vendor's own batch purity, which remains undocumented anywhere on the site.
There is no laboratory to verify. Every purity and testing claim on scyrx.com traces back to the vendor's own copy, never to a named lab's own site the way the labs behind the other two vendors in this wave can be checked. The homepage carries five testimonial blurbs attributed to named individuals, for example a reviewer credited as "Dr. Sarah M., Immunology Researcher" and another as "James R., Exercise Science Lab, UCLA," each citing a specific purity reading for a named compound. These are the vendor's own marketing copy, printed twice on the same page in what reads as a duplicated carousel block, and I did not regard them as independent corroboration since no institution, credential, or contactable source backs any of the five. The site links out to a second domain, peptideresearchnetwork.com, styled on both the homepage and the Retatrutide product page as a place to explore peer-reviewed research and sourcing standards. Fetched today, peptideresearchnetwork.com's home page is a near-empty page shell, titled for global sourcing and standards, with no server-rendered body content beyond that title. It is built, like scyrx.com itself, on the Lovable no-code platform: each site carries a live "Edit with Lovable" developer badge in its markup, linking to a distinct Lovable project ID for each domain. I could not confirm any operating relationship between the two beyond the cross-link and the shared build tooling, and peptideresearchnetwork.com is not itself a laboratory, testing body, or accreditation authority. The Retatrutide product page does cite six real peer-reviewed publications by title, journal, and DOI, including a 2023 New England Journal of Medicine phase 2 trial, a 2024 Nature Medicine trial, and a 2022 Lancet phase 1b trial. All of them describe the pharmaceutical development of retatrutide in general; none is a laboratory report on any batch this vendor has sold, and the page does not claim otherwise.
Catalog and pricing, read 2026-08-26. sitemap.xml lists 41 URLs, of which 26 are individual /product/ pages: 23 single compounds (BPC-157, CJC-1295 No DAC, DSIP, Epithalon, GHK-Cu, GHRP-2, GHRP-6, IGF-1 LR3, Ipamorelin, Kisspeptin-10, KPV, Melanotan-2, MOTS-c, Retatrutide, Selank, Semaglutide, Semax, Sermorelin Acetate, SS-31, TB-500, Tesamorelin, Thymosin Alpha-1, Tirzepatide) plus three pre-mixed stacks (GLOW, KLOW, Wolverine Stack), organized under eight subject-matter category pages (Metabolic, Recovery, Longevity, Cognition, Hormonal, Immune, Cardiovascular, and Stacks), plus an Accessories page selling one item, a branded delivery pen at a promotional price. Retatrutide is a genuine listing here, unlike the other two vendors in this wave. Retatrutide 10mg is priced at $32.00 USD, marked in stock, on the product page titled "Retatrutide - Triple GLP-1/GIP/Glucagon Receptor Agonist." The same page lists five other vial sizes: 5mg at $22.00 (sold out), 20mg at $50.00, 30mg at $65.00 (sold out), 40mg at $78.00, and 60mg at $95.00, plus an automatic 5 percent discount stated for orders of three or more items. For reference, the same catalog prices Semaglutide 5mg and Tirzepatide 5mg at $15.00 each, BPC-157 5mg at $12.00, and TB-500 10mg at $42.00. Payment: the homepage lists its payment options as Credit Card, Zelle, eCheck, CashApp, ACH Transfer, and Bitcoin or other crypto, with a row of network badges reading Visa, Mastercard, Discover, Zelle, CashApp, Bitcoin, ACH, and eCheck repeated in the footer of every page fetched. Shipping and ship-to: the product page and homepage both assert domestic United States fulfillment, describing the business as USA sourced and distributed, shipped from a US facility with worldwide support, and United States based while shipping worldwide, plus a 2-day shipping guarantee backed by a stated $15 credit if a shipment runs late. None of this is backed by an actual shipping policy: the /shipping URL returns a 404 page-not-found response. No shipping rate, carrier, delivery-time range by region, or list of countries served appears on any page I fetched; the 2-day guarantee's own conditions, such as which orders qualify or what counts as late, are not published anywhere I could find. Entity and contact: /contact, /terms, and /privacy all return the same 404 page-not-found template as /shipping. The only working contact channel across every page I fetched is one email address, support@scyrx.com, given in the site's schema.org structured data as a generic contact point with area served listed as worldwide. That same structured-data block names the organization only as "SCYRX," with no legal suffix such as LLC, Inc., or Ltd., no street address, no phone number, and no state of registration anywhere in the pages I fetched.
CAUTIONCautions noted, all supported by pages fetched today. First, and most significant, there is no certificate of analysis anywhere on the site: not for Retatrutide, not for any of the other 25 catalog items. Every purity figure on the product pages and homepage is vendor-stated marketing copy; the actual document is gated behind an email request the vendor says takes up to one business day, and no named testing laboratory backs any of it. Second, the standard commerce and legal pages a buyer would expect are simply missing: /contact, /shipping, /terms, and /privacy each return a 404, despite footer links on every page labelled Contact, Shipping, Terms, and Privacy, all of which point to a dead "#" anchor rather than a real URL. Third, the entity behind the site is effectively anonymous in the pages I fetched: no legal name beyond the brand "SCYRX," no address, no phone number, and one support email as the sole contact route. Fourth, the site itself displays a live "Edit with Lovable" developer badge, indicating it is built on a no-code AI website platform, and combined with the missing legal pages, reads as a newly assembled storefront rather than an established operation with reference documentation in place. Fifth, the homepage's testimonial section is unverifiable vendor marketing: five named reviewer quotes citing specific batch-purity readings, printed twice on the same page as a duplicated block, with no way to confirm any of the five people, institutions, or purity claims independently. Sixth, the Purity Promise refund guarantee places the burden of proof on the buyer's own outside testing rather than on a document the vendor supplies before purchase, and since /terms 404s, the guarantee's actual conditions are not published anywhere I could find. No age-verification requirement appears on any page I fetched, in contrast to the other two vendors in this wave, which both state one (inconsistently, in Research Peptides Europe's case).
Reader reviews
No reader review of this supplier is published yet. Every review is read and checked against the record before it appears. Add a review.
Open this supplier
Some supplier links here are referral links, marked where they appear, which pay Terminus Research when a reader buys. The same terms are open to every supplier in the ledger, apart from the one exception the referral policy page names, participation changes no score, rank, caution, or coverage decision, and a link is not an endorsement.